<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	
	xmlns:media="http://search.yahoo.com/mrss/"
	>

<channel>
	<title>Stevens Johnson Syndrome &#187; NSAIDS</title>
	<atom:link href="http://www.sjs-legal.com/tag/nsaids/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.sjs-legal.com</link>
	<description></description>
	<lastBuildDate>Wed, 28 Jul 2010 20:36:18 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Pepcid linked to serious skin reaction</title>
		<link>http://www.sjs-legal.com/news/2010/07/07/pepcid-linked-to-serious-skin-reaction/</link>
		<comments>http://www.sjs-legal.com/news/2010/07/07/pepcid-linked-to-serious-skin-reaction/#comments</comments>
		<pubDate>Wed, 07 Jul 2010 15:09:29 +0000</pubDate>
		<dc:creator>Jennifer Walker-Journey</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[anti-seizure drugs]]></category>
		<category><![CDATA[antibiotics]]></category>
		<category><![CDATA[black box warning]]></category>
		<category><![CDATA[deadly skin reaction]]></category>
		<category><![CDATA[Famotidine]]></category>
		<category><![CDATA[gastroesophageal reflux disease]]></category>
		<category><![CDATA[GERD]]></category>
		<category><![CDATA[heartburn drug]]></category>
		<category><![CDATA[lawyer]]></category>
		<category><![CDATA[metoclopramide]]></category>
		<category><![CDATA[NSAIDS]]></category>
		<category><![CDATA[Pepcid]]></category>
		<category><![CDATA[PPIs]]></category>
		<category><![CDATA[proton pump inhibitors]]></category>
		<category><![CDATA[Reglan]]></category>
		<category><![CDATA[side effects]]></category>
		<category><![CDATA[SJS]]></category>
		<category><![CDATA[Stevens Johnson Syndrome]]></category>
		<category><![CDATA[tardeive dyskinesia]]></category>
		<category><![CDATA[TEN]]></category>
		<category><![CDATA[toxic epidermal necrolysis]]></category>
		<category><![CDATA[ulcers]]></category>

		<guid isPermaLink="false">http://www.sjs-legal.com/?p=870</guid>
		<description><![CDATA[Famotidine, the heartburn drug most known by the brand name Pepcid, is yet another drug that has been linked to a deadly skin reaction known as toxic epidermal necrolysis (TEN), the most serious version of Stevens Johnson Syndrome (SJS). Famotidine is available by both prescription and over-the-counter in either a tablet or suspension (liquid) that [...]<p>SOURCE: <a href="http://www.sjs-legal.com">Stevens Johnson Syndrome</a> &rsaquo; <a href="http://www.sjs-legal.com/news/2010/07/07/pepcid-linked-to-serious-skin-reaction/">Pepcid linked to serious skin reaction</a></p>
]]></description>
			<content:encoded><![CDATA[<p><img class="alignleft size-thumbnail wp-image-871" src="http://www.sjs-legal.com/media/2010/07/th-50174-45470-famotidine-100x100.jpg" alt="th 50174 45470 famotidine 100x100" width="100" height="100" title="Pepcid linked to serious skin reaction photo" /><strong>Famotidine</strong>, the <strong>heartburn drug</strong> most known by the brand name <strong>Pepcid</strong>, is yet another drug that has been linked to a <strong>deadly skin reaction</strong> known as <strong><a href="http://www.sjs-legal.com/toxic-epidermal-necrolysis-syndrome/" title="" rel="external">toxic epidermal necrolysis</a> (TEN)</strong>, the most serious version of <strong><a href="http://www.sjs-legal.com/" title="" rel="external">Stevens Johnson Syndrome</a> (<a href="http://www.sjs-legal.com/tag/sjs/" class="st_tag internal_tag" rel="tag" title="Posts tagged with SJS">SJS</a>)</strong>. Famotidine is available by both prescription and over-the-counter in either a tablet or suspension (liquid) that is taken by mouth. It is in a class of medications called H2 blockers and works by decreasing the amount of acid made in the stomach. Famotidine is used to treat <strong>ulcers, gastroesophageal reflux disease (GERD)</strong>, and conditions where the stomach produces too much acid.<span id="more-870"></span></p>
<p><strong>Side effects</strong> from famotidine are usually mild and include headache, dizziness, constipation, diarrhea and fussiness, however more serious effects such as hives, skin rashes and swelling have been reported. While reports of TEN associated with famotidine are rare, the condition can be life threatening.</p>
<p><a href="http://www.sjs-legal.com/tag/sjs/" class="st_tag internal_tag" rel="tag" title="Posts tagged with SJS">SJS</a>/TEN have been associated with as many as 2,000 medications, most often <strong>NSAIDs, <a href="http://www.sjs-legal.com/tag/antibiotics/" class="st_tag internal_tag" rel="tag" title="Posts tagged with antibiotics">antibiotics</a> </strong>and<strong> anti-seizure drugs</strong>. <a href="http://www.sjs-legal.com/tag/sjs/" class="st_tag internal_tag" rel="tag" title="Posts tagged with SJS">SJS</a>/TEN begins with a rash that blisters over causing the skin to slough off in sheets. Blisters can also form on the mucous membranes affecting the eyes, nose, mouth and genitals.</p>
<p>Famotidine is not a <strong>proton pump inhibitor (PPI)</strong> and thus was not among the heartburn drugs cited by a recent <a href="http://www.beasleyallen.com/news/Prescription,-OTC-proton-heartburn-meds-linked-to-wrist,-hip,-spine-fractures/">Food and Drug Administration (FDA) warning</a> about the increased risk of wrist, hip and spine fractures with PPIs. Another heartburn medication, <a href="http://www.reglan-lawyer.net/"><strong><a href="http://www.reglan-lawyer.net/" title="" rel="external">Reglan</a> (<a href="http://www.reglan-lawyer.net/tag/metoclopramide/" title="" rel="external">metoclopramide</a>),</strong></a> has also fallen under an FDA <strong>black box warning</strong> after reports of consumers who took the medication developed a serious movement disorder known as <strong><a href="http://www.reglan-lawyer.net/reglan-side-effects/tardive-dyskinesia/" title="" rel="external">Tardive Dyskinesia</a></strong>.</p>
<p>SOURCE: <a href="http://www.sjs-legal.com">Stevens Johnson Syndrome</a> &rsaquo; <a href="http://www.sjs-legal.com/news/2010/07/07/pepcid-linked-to-serious-skin-reaction/">Pepcid linked to serious skin reaction</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.sjs-legal.com/news/2010/07/07/pepcid-linked-to-serious-skin-reaction/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:thumbnail url="http://www.sjs-legal.com/media/2010/07/th-50174-45470-famotidine-100x100.jpg" />
		<media:content url="http://www.sjs-legal.com/media/2010/07/th-50174-45470-famotidine.jpg" medium="image">
			<media:title type="html">th-50174-45470-famotidine</media:title>
			<media:thumbnail url="http://www.sjs-legal.com/media/2010/07/th-50174-45470-famotidine-100x100.jpg" />
		</media:content>
	</item>
		<item>
		<title>HIV medication carries warning of SJS</title>
		<link>http://www.sjs-legal.com/news/2009/01/23/hiv-medication-carries-warning-of-sjs/</link>
		<comments>http://www.sjs-legal.com/news/2009/01/23/hiv-medication-carries-warning-of-sjs/#comments</comments>
		<pubDate>Fri, 23 Jan 2009 14:00:42 +0000</pubDate>
		<dc:creator>Jennifer Walker-Journey</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[adverse reactions]]></category>
		<category><![CDATA[AIDS]]></category>
		<category><![CDATA[antibiotic]]></category>
		<category><![CDATA[antibiotics]]></category>
		<category><![CDATA[darunavir]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[ibuprofen]]></category>
		<category><![CDATA[NSAID]]></category>
		<category><![CDATA[NSAIDS]]></category>
		<category><![CDATA[Preista]]></category>
		<category><![CDATA[rashes]]></category>
		<category><![CDATA[reactions to medication]]></category>
		<category><![CDATA[SJS]]></category>
		<category><![CDATA[St. John's Wort]]></category>
		<category><![CDATA[Stevens Johnson Syndrome]]></category>
		<category><![CDATA[TENS]]></category>
		<category><![CDATA[Tibotec]]></category>
		<category><![CDATA[toxic epidermal necrolysis]]></category>

		<guid isPermaLink="false">http://www.sjs-legal.com/?p=344</guid>
		<description><![CDATA[The FDA recently approved safety labeling revisions for darunavir tablets, also known as Prezista, to warn of adverse reactions including skin rashes and Stevens Johnson Syndrome (SJS), according to MedScape.
Darunavir, manufactured by Tibotec, belongs to a class of anti-HIV drugs called protease inhibitors (PI). It works to prevent cells infected by HIV from producing new virus, [...]<p>SOURCE: <a href="http://www.sjs-legal.com">Stevens Johnson Syndrome</a> &rsaquo; <a href="http://www.sjs-legal.com/news/2009/01/23/hiv-medication-carries-warning-of-sjs/">HIV medication carries warning of SJS</a></p>
]]></description>
			<content:encoded><![CDATA[<p>The <strong>FDA</strong> recently approved safety labeling revisions for <strong>darunavir</strong> tablets, also known as <strong>Prezista</strong>, to warn of <strong>adverse reactions</strong> including skin rashes and <a href="http://www.sjs-legal.com"><strong><a href="http://www.sjs-legal.com/" title="" rel="external">Stevens Johnson Syndrome</a> (SJS)</strong></a><strong>,</strong> according to <a href="http://www.medscape.com/viewarticle/587156">MedScape</a>.<span id="more-344"></span></p>
<p><strong>Darunavir</strong>, manufactured by <strong>Tibotec</strong>, belongs to a class of <strong>anti-HIV</strong> drugs called protease inhibitors (PI). It works to prevent cells infected by <strong>HIV</strong> from producing new virus, thus reducing the amount of virus in the body. <strong>Darunavir</strong> must be coadministered with 100-mg ritonavir and with other antiretroviral agents. It was approved by the <strong>FDA</strong> in June 2006 for <strong>HIV</strong>-positive adults who were treatment-experienced.</p>
<p>Last October, <strong>darunavir</strong> was approved for <strong>HIV</strong>-positive individuals beginning treatment. The medication has proven effective for patients who are not likely to respond to older PIs and for those who are starting antiretroviral therapy for the first time.</p>
<p><strong><a href="http://www.sjs-legal.com/tag/sjs/" class="st_tag internal_tag" rel="tag" title="Posts tagged with SJS">SJS</a></strong> and its more severe form, <a href="http://www.sjs-legal.com"><strong><a href="http://www.sjs-legal.com/toxic-epidermal-necrolysis-syndrome/" title="" rel="external">toxic epidermal necrolysis</a> (TEN),</strong></a> are <strong>serious adverse reactions to medication</strong>. The reaction begins with a rash that blisters over, causing the skin to peel off in sheets. Mucus membranes in the eyes and mouth also can blister over, leading to dehydration, infection, blindness, and even death. More than 200 medications have been linked to <strong><a href="http://www.sjs-legal.com/tag/sjs/" class="st_tag internal_tag" rel="tag" title="Posts tagged with SJS">SJS</a></strong> and <strong>TEN</strong>, including <strong>NSAIDs</strong> such as <strong>ibuprofen</strong>, <strong><a href="http://www.sjs-legal.com/tag/antibiotics/" class="st_tag internal_tag" rel="tag" title="Posts tagged with antibiotics">antibiotics</a></strong> and <strong>anti-seizure</strong> medication.</p>
<p>Other warning included in the labeling revisions for <strong>darunavir</strong> include warnings of potential drug-drug interactions and pregnancy risk. <strong>Darunavir</strong> should not be taken with dihydroergotamine, ergonovine, ergotamine, methylergonovine, cisapride, pimozide, oral midazolam, triazolam, St. John&#8217;s Wort, lovastatin, simvastatin, or rifampin.</p>
<p><strong>Darunavir</strong> also should be taken during pregnancy only if the potential benefit justifies the potential risk, according to the report. Mothers on <strong>darunavir</strong> should not breast feed, and children younger than 3 should not take <strong>darunavir</strong>.</p>
<p>SOURCE: <a href="http://www.sjs-legal.com">Stevens Johnson Syndrome</a> &rsaquo; <a href="http://www.sjs-legal.com/news/2009/01/23/hiv-medication-carries-warning-of-sjs/">HIV medication carries warning of SJS</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.sjs-legal.com/news/2009/01/23/hiv-medication-carries-warning-of-sjs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
	</item>
		<item>
		<title>Stimulant drug added to list of meds that can cause SJS/TEN</title>
		<link>http://www.sjs-legal.com/news/2009/01/08/stimulant-drug-added-to-list-of-meds-that-can-cause-sjsten/</link>
		<comments>http://www.sjs-legal.com/news/2009/01/08/stimulant-drug-added-to-list-of-meds-that-can-cause-sjsten/#comments</comments>
		<pubDate>Thu, 08 Jan 2009 14:00:00 +0000</pubDate>
		<dc:creator>Jennifer Walker-Journey</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[adverse reaction to medication]]></category>
		<category><![CDATA[adverse reactions]]></category>
		<category><![CDATA[AIDS]]></category>
		<category><![CDATA[anti-seizure medication]]></category>
		<category><![CDATA[antibiotic]]></category>
		<category><![CDATA[antibiotics]]></category>
		<category><![CDATA[Cephalon]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[modafinil]]></category>
		<category><![CDATA[Modafinil Provigil)]]></category>
		<category><![CDATA[NSAID]]></category>
		<category><![CDATA[NSAIDS]]></category>
		<category><![CDATA[prescriptions]]></category>
		<category><![CDATA[provigil]]></category>
		<category><![CDATA[rashes]]></category>
		<category><![CDATA[SJS]]></category>
		<category><![CDATA[Stevens Johnson Syndrome]]></category>
		<category><![CDATA[TENS]]></category>
		<category><![CDATA[toxic epidermal necrolysis]]></category>

		<guid isPermaLink="false">http://www.sjs-legal.com/?p=265</guid>
		<description><![CDATA[A stimulant-type drug recently was added to the list of medications that may cause Stevens Johnson Syndrome (SJS), a rare but life-threatening condition affecting the skin and mucus membranes, causing the skin to blister and peel away in sheets. MedPage Today reported that drug maker Cephalon has agreed to update the drug’s label to warn [...]<p>SOURCE: <a href="http://www.sjs-legal.com">Stevens Johnson Syndrome</a> &rsaquo; <a href="http://www.sjs-legal.com/news/2009/01/08/stimulant-drug-added-to-list-of-meds-that-can-cause-sjsten/">Stimulant drug added to list of meds that can cause SJS/TEN</a></p>
]]></description>
			<content:encoded><![CDATA[<p>A stimulant-type drug recently was added to the list of medications that may cause <a href="http://www.sjs-legal.com"><strong><a href="http://www.sjs-legal.com/" title="" rel="external">Stevens Johnson Syndrome</a> (SJS)</strong></a>, a rare but life-threatening condition affecting the skin and mucus membranes, causing the skin to <strong>blister and peel away in sheets</strong>. <a href="http://www.medpagetoday.com/ProductAlert/Prescriptions/7108">MedPage Today</a> reported that drug maker <strong>Cephalon</strong> has agreed to update the drug’s label to warn of the potential risk of <strong><a href="http://www.sjs-legal.com/tag/sjs/" class="st_tag internal_tag" rel="tag" title="Posts tagged with SJS">SJS</a></strong> and other <strong>serious rashes and hypersensitivity reactions</strong>.<span id="more-265"></span></p>
<p><strong>Modafinil (Provigil) </strong>is approved by the <strong>FDA</strong> to treat <strong>narcolepsy</strong> and <strong>excessive daytime sleepiness</strong> associated with obstructive sleep apnea. <strong>Modafinil (Provigil)</strong> also has been shown effective in the treatment of <strong>depression, cocaine addition, Parkinson’s Disease</strong> and <strong>schizophrenia</strong>, though the <strong>FDA</strong> has not approved the drug for those conditions. It also was thought to be an effective treatment for <strong>Attention-Deficit Hyperactivity Disorder (ADHD),</strong> however in 2006 it was rejected by the <strong>FDA</strong> for use by children for <strong>ADHD</strong>. <strong>Cephalon</strong> now discourages the drug&#8217;s use in children for any purpose.</p>
<p>Since December 1998, when <strong>Modafini (Provigil) </strong>was introduced to the market until January 30, 2007, seven cases of seven cases of <strong>severe cutaneous adverse reactions</strong> to the medicine were reported to the <strong>FDA</strong>. Those cases included <strong><a href="http://www.sjs-legal.com/tag/sjs/" class="st_tag internal_tag" rel="tag" title="Posts tagged with SJS">SJS</a></strong> and its more severe form, <a href="http://www.sjs-legal.com"><strong><a href="http://www.sjs-legal.com/toxic-epidermal-necrolysis-syndrome/" title="" rel="external">toxic epidermal necrolysis</a> (TEN)</strong></a><strong>.</strong></p>
<p><strong><a href="http://www.sjs-legal.com/tag/sjs/" class="st_tag internal_tag" rel="tag" title="Posts tagged with SJS">SJS</a></strong> and <strong>TEN</strong> has a reported incidence rate of about one case per million people each year. It is most often caused by an <strong>adverse reaction to medication</strong>. Medications that have been linked to <strong><a href="http://www.sjs-legal.com/tag/sjs/" class="st_tag internal_tag" rel="tag" title="Posts tagged with SJS">SJS</a></strong> and <strong>TEN</strong> include <strong>NSAIDS (non-steroidal anti-inflamatory agents), anti-seizure medications </strong>and some<strong> <a href="http://www.sjs-legal.com/tag/antibiotics/" class="st_tag internal_tag" rel="tag" title="Posts tagged with antibiotics">antibiotics</a></strong>.</p>
<p>SOURCE: <a href="http://www.sjs-legal.com">Stevens Johnson Syndrome</a> &rsaquo; <a href="http://www.sjs-legal.com/news/2009/01/08/stimulant-drug-added-to-list-of-meds-that-can-cause-sjsten/">Stimulant drug added to list of meds that can cause SJS/TEN</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.sjs-legal.com/news/2009/01/08/stimulant-drug-added-to-list-of-meds-that-can-cause-sjsten/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
	</item>
	</channel>
</rss>
